Literature DB >> 3592132

Hodgkin's disease in pediatric patients with naturally occurring immunodeficiency.

L L Robison, V Stoker, G Frizzera, K Heinitz, A T Meadows, A H Filipovich.   

Abstract

A case/control study of pediatric patients with Hodgkin's disease (HD) was undertaken to compare clinical characteristics in patients with known underlying immunodeficiency (20 Immunodeficiency Cancer Registry cases) and without known immunodeficiency (100 Late Effects Study Group cases). Immunodeficiency Cancer Registry cases demonstrated a younger mean age at diagnosis (p = 0.03), and a significantly higher rate of failure to achieve remission (p = 0.001) than did the Late Effects Study Group controls. Also, Immunodeficiency Cancer Registry cases showed a proportional excess of unfavorable histologies when compared with large published pediatric series. These discrepancies are consistent with a common etiology of HD relating to underlying immune defect in Immunodeficiency Cancer Registry HD patients as well as HD patients (or a select subgroup) without known immunodeficiency disorders.

Entities:  

Mesh：

Year:  1987        PMID： 3592132     DOI： 10.1097/00043426-198722000-00019

Source DB:  PubMed          Journal:  Am J Pediatr Hematol Oncol        ISSN： 0192-8562


  5 in total

1.  Increased frequency of hematopoietic malignancies in relatives of patients with lymphoid neoplasms: a French case-control study.

Authors:  Sara Villeneuve; Laurent Orsi; Alain Monnereau; Christian Berthou; Pierre Fenaux; Gerald Marit; Pierre Soubeyran; Françoise Huguet; Noël Milpied; Michel Leporrier; Denis Hemon; Xavier Troussard; Jacqueline Clavel
Journal:  Int J Cancer       Date:  2009-03-01       Impact factor: 7.396

2.  Malignancies after hematopoietic cell transplantation for primary immune deficiencies: a report from the Center for International Blood and Marrow Transplant Research.

Authors:  Naynesh R Kamani; Shimareet Kumar; Anna Hassebroek; Mary Eapen; Jennifer LeRademacher; James Casper; Morton Cowan; José Sánchez de Toledo; Alina Ferster; Paul Szabolcs; John R Wingard; Edwin Horwitz; Alexandra H Filipovich
Journal:  Biol Blood Marrow Transplant       Date:  2011-05-20       Impact factor: 5.742

3.  Lymphoma Secondary to Congenital and Acquired Immunodeficiency Syndromes at a Turkish Pediatric Oncology Center.

Authors:  Hikmet G Tanyildiz; Handan Dincaslan; Gulsan Yavuz; Emel Unal; Aydan Ikinciogulları; Figen Dogu; Nurdan Tacyildiz
Journal:  J Clin Immunol       Date:  2016-08-04       Impact factor: 8.317

4.  Cancer in primary immunodeficiency diseases: Cancer incidence in the United States Immune Deficiency Network Registry.

Authors:  Paul C Mayor; Kevin H Eng; Kelly L Singel; Scott I Abrams; Kunle Odunsi; Kirsten B Moysich; Ramsay Fuleihan; Elizabeth Garabedian; Patricia Lugar; Hans D Ochs; Francisco A Bonilla; Rebecca H Buckley; Kathleen E Sullivan; Zuhair K Ballas; Charlotte Cunningham-Rundles; Brahm H Segal
Journal:  J Allergy Clin Immunol       Date:  2017-06-09       Impact factor: 10.793

5.  The paradigm of hematological malignant versus non-malignant manifestations, driven by primary immunodeficiencies: a complex interplay.

Authors:  C Kelaidi; V Tzotzola; S Polychronopoulou
Journal:  Fam Cancer       Date:  2021-06-15       Impact factor: 2.375
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.